SCHEMBL31205486

SCHEMBL31205486

COc1c(C(=O)O)ccn2nccc12

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 7/20 0.37
KDM4E B2RXH2 6/20 0.37
HSD17B10 Q99714 4/20 0.37
LMNA P02545 1/20 0.37
APEX1 P27695 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.35
EPHB3 P54753 1/20 0.35
HPGD P15428 3/20 0.35
NOTUM Q6P988 2/20 0.35
POLB P06746 2/20 0.35
HTT P42858 2/20 0.35
MAPK1 P28482 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GAA P10253 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31205650 0.86 KDM4E (0.39) MAPTALDH1A1KDM4EHSD17B10LMNA
SCHEMBL3076453 0.80 NOTUM (0.42) TDP1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL31205040 0.78 ALDH1A1 (0.38) MAPTALDH1A1KDM4EHSD17B10LMNA
SCHEMBL31205416 0.76 KDM4E (0.33) MAPTALDH1A1KDM4EHSD17B10LMNA
SCHEMBL23441032 0.76 KDM4E (0.43) TDP1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL25242656 0.76 L3MBTL1 (0.36) TDP1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL31205461 0.75 GAA (0.32) ALDH1A1KDM4EMAPK1GAA
SCHEMBL28619579 0.74 TSHR (0.42) TDP1MAPTALDH1A1KDM4ELMNA
SCHEMBL31205096 0.73 GAA (0.41) MAPTALDH1A1KDM4EHSD17B10EPHB3
SCHEMBL29548353 0.73 NQO2 (0.37) ALDH1A1KDM4EHSD17B10HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727941-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF Lynk Pharmaceuticals Co. Ltd. (CN) 2026-04-22 EP disclosed
WO-2024255164-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2024-12-19 WO disclosed
WO-2024255885-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2024-12-19 WO disclosed
WO-2024254834-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2024-12-19 WO disclosed